Genetic Variation in the Magnitude and Longevity of the IgG Subclass Response to a Diphtheria-Tetanus-Acellular Pertussis (DTaP) Vaccine in Mice

被引:8
|
作者
Mosley, Yung-Yi C. [1 ]
Radder, Josiah E. [2 ]
HogenEsch, Harm [1 ,3 ]
机构
[1] Purdue Univ, Dept Comparat Pathobiol, Coll Vet Med, W Lafayette, IN 47907 USA
[2] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15219 USA
[3] Indiana Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, Purdue Univ, W Lafayette, IN 47907 USA
关键词
DTaP; vaccine; IgG subclass; antibody magnitude; antibody longevity; genetics; GENOME-WIDE ASSOCIATION; INTERFERON-GAMMA; IMMUNE-RESPONSE; ANTIBODY-RESPONSES; WHOLE-CELL; RECEPTOR; TOXIN; MOUSE; INDUCTION; ADJUVANT;
D O I
10.3390/vaccines7040124
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The type of IgG subclasses induced by vaccination is an important determinant of vaccine efficacy because the IgG subclasses vary in their biological function. The goal of this study was to determine the influence of the genetic background on the production and duration of vaccine-induced IgG subclasses. IgG1, IgG2b, and IgG3 titers against diphtheria toxoid (DT), pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (Prn) were measured in mice from 28 different inbred and wild-derived strains vaccinated with an aluminum hydroxide-adjuvanted DTaP vaccine. The titers and duration of vaccine-specific IgG subclass responses were different among mouse strains, indicating that genetic factors contribute to this variation. Statistical associations were used to identify potential mechanisms that contribute to antibody production and longevity. This analysis showed that the mechanisms guiding the magnitude of antibody production were antigen-dependent for IgG1 but antigen-independent for IgG2b and IgG3. However, the mechanisms driving the longevity of antibody titers were antigen-independent for IgG1, IgG2b, and IgG3. The ratio of IgG1 and IgG3 titers identified Th1 and Th2-prone mouse strains. TLR4-deficient C3H/HeJ mice had an enhanced IgG1 response compared with C3H/HeOuJ mice with intact TLR4. This work demonstrates that the genetic background contributes significantly to the magnitude and longevity of vaccine-induced IgG1, IgG2b, and IgG3 titers in mice.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Diphtheria-tetanus-acellular pertussis (DTaP) vaccine
    Howe, BJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22): : 1803 - 1803
  • [2] Diphtheria-tetanus-acellular pertussis (DTaP) vaccine - Reply
    Marwick, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22): : 1804 - 1804
  • [3] Overview of the clinical development of a diphtheria-tetanus-acellular pertussis vaccine
    Bogaerts, H
    Capiau, C
    Hauser, P
    Mareschal, JC
    Melot, V
    Simons, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 174 : S276 - S280
  • [4] Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults
    Van Damme, P
    Burgess, M
    [J]. VACCINE, 2004, 22 (3-4) : 305 - 308
  • [5] A diphtheria-tetanus-acellular pertussis vaccine for adults: the wrong booster vaccine for Australia?
    Kelly, HA
    Andrews, RM
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (03) : 173 - 174
  • [6] Immunogenicity and reactogenicity of a single dose of a diphtheria-tetanus-acellular pertussis component vaccine (DTaP) compared to a diphtheria-tetanus toxoid (Td) and a diphtheria toxoid vaccine (d) in adults
    Bartels, I
    Jüngert, J
    Lugauer, S
    Stehr, K
    Heininger, U
    [J]. VACCINE, 2001, 19 (23-24) : 3137 - 3145
  • [7] Safety of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccine in Adults in Japan
    Ujiie, Mugen
    Tsuzuki, Shinya
    Suzuki, Michiyo
    Ota, Masayuki
    Suzuki, Tetsuya
    Nomoto, Hidetoshi
    Yamamoto, Kei
    Saito, Sho
    Kokaze, Akatsuki
    Kinoshita, Noriko
    [J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2021, 74 (05) : 399 - 404
  • [8] Interfering effect of diphtheria-tetanus-acellular pertussis combined (DTaP) vaccines on the bacterial endotoxin test
    Ochiai, M
    Yamamoto, A
    Kataoka, M
    Toyoizumi, H
    Horiuchi, Y
    [J]. BIOLOGICALS, 2001, 29 (01) : 55 - 58
  • [9] A diphtheria-tetanus-acellular pertussis vaccine for adults: the wrong booster vaccine for Australia? Reply
    Ruff, TA
    Bogaerts, HH
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (03) : 174 - 174
  • [10] Reduced-Antigen Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine (Boostrix™)
    Therese M. Chapman
    Karen L. Goa
    [J]. Drugs, 2003, 63 : 1407 - 1413